agilon health, inc. (NYSE:AGL) Shares Sold by Amalgamated Bank

Amalgamated Bank trimmed its position in agilon health, inc. (NYSE:AGLFree Report) by 46.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,382 shares of the company’s stock after selling 8,921 shares during the quarter. Amalgamated Bank’s holdings in agilon health were worth $68,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of AGL. Neo Ivy Capital Management bought a new stake in agilon health in the 4th quarter valued at about $47,000. J.Safra Asset Management Corp increased its holdings in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares during the last quarter. CWM LLC raised its stake in agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new stake in agilon health during the second quarter worth about $60,000. Finally, Bleakley Financial Group LLC bought a new stake in agilon health in the first quarter valued at about $65,000.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on AGL shares. Evercore ISI boosted their price objective on agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 9th. Royal Bank of Canada reiterated an “outperform” rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Benchmark reiterated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $8.57.

Read Our Latest Stock Report on AGL

Insider Activity at agilon health

In related news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. The purchase was disclosed in a document filed with the SEC, which is available through this link. 3.20% of the stock is owned by company insiders.

agilon health Stock Performance

Shares of AGL stock opened at $3.67 on Wednesday. agilon health, inc. has a 12 month low of $3.07 and a 12 month high of $20.37. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.51 billion, a PE ratio of -5.24 and a beta of 0.54. The company’s fifty day simple moving average is $4.71 and its 200-day simple moving average is $5.43.

agilon health (NYSE:AGLGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.07). The company had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The business’s revenue was up 38.7% on a year-over-year basis. During the same period last year, the firm posted ($0.04) earnings per share. Equities research analysts expect that agilon health, inc. will post -0.32 EPS for the current fiscal year.

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.